Is Compounded Semaglutide Effective for Weight Loss?
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
What is compounded semaglutide and is it safe? The more affordable weight loss drugs Hims & Hers is selling, explained.
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Pros and cons of weight-loss jabs
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Higher max dose guidance for semaglutide offers hope
A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...
phillyvoice.com1d
Weight-loss drugs Ozempic, Wegovy help people drink less and smoke fewer cigarettes, new research finds
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
Ozempic Can Curb Drinking, New Research Shows
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
ZME Science on MSN20h
Ozempic Users Are Drinking Less Alcohol Without Even Trying
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Weight-loss jabs can cut alcohol cravings, study suggests
Drug sold under brand names Ozempic and Wegovy appears to stop people hankering after other addictive substances ...
New Atlas2d
Ozempic dials down alcohol cravings for people wanting to cut back
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says
The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use ...
Fierce Healthcare1d
Primary care doctors concerned about telehealth GLP-1 boom: survey
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...